DEA registration denial and revocation proceedings for practitioners turn on five statutory public interest factors, codified at 21 U.S.C. § 823(g)(1) (formerly § 823(f), before a 2022 redesignation). DEA weighs the factors in the disjunctive, meaning any single factor, standing alone, can support denial or revocation of a controlled substance registration. A pharmacist-in-charge served with a DEA order to show cause faces a narrower practical reality than the five-factor list suggests: DEA's own final orders turn less on which factors apply than on whether the record demonstrates acceptance of responsibility.
The Five Statutory Public Interest Factors
Section 823(g)(1) directs the Attorney General, and by delegation DEA, to weigh five factors when a practitioner's registration is at issue: the recommendation of the appropriate state licensing board or professional disciplinary authority; the applicant's experience dispensing or researching controlled substances; the applicant's conviction record under federal or state controlled substance law; the applicant's compliance record with state, federal, or local controlled substance law; and any other conduct that may threaten public health and safety. DEA need not find fault under all five; a single factor, if the evidence is strong enough, can carry a denial or revocation on its own.
How DEA Weighs the Factors in Practice
DEA treats the five factors as independent grounds, and a clean record on one factor carries little weight once misconduct is established under another. In practitioner cases, DEA's final orders lean most heavily on the applicant's experience dispensing controlled substances and the applicant's compliance record. In Debora Ryder, N.P., 88 Fed. Reg. 55074 (Aug. 14, 2023), DEA revoked a nurse practitioner's registration after finding she issued controlled substance prescriptions in the names of deceased patients, treating those two factors as decisive despite the absence of any state board discipline against her. A companion piece examines how the same public interest factors apply to registration denials on a new or renewal application, a distinct posture from the revocation proceeding above.
Acceptance of Responsibility as a Threshold Requirement
DEA final orders treat acceptance of responsibility as a threshold a registrant must clear before remedial measures enter the analysis at all. The Ryder order restates the standard DEA applies across practitioner cases: a registrant who has committed acts inconsistent with the public interest must accept responsibility for those acts and demonstrate that corrective measures have been undertaken. An equivocal acceptance carries no weight; a registrant who hedges, minimizes, or shifts blame to staff or systems has not cleared the threshold, and DEA does not reach the question of remedial measures once that threshold is missed. A registrant who never requests a hearing and submits no corrective plan forecloses the inquiry before it starts.
Acceptance of responsibility must be unequivocal, and DEA need not weigh remedial measures until that threshold is met.
Building a Record on Acceptance of Responsibility
A pharmacy or practitioner preparing for a contested proceeding, or responding before DEA issues an order to show cause or an immediate suspension order, should treat the acceptance-of-responsibility record as its central work product, not a hearing afterthought. Candor with investigators before any charges issue carries independent weight toward a credible acceptance later in the proceeding. The corrective measures that follow need to be specific and documented, not asserted at the hearing for the first time: documented inventory reconciliation showing an identified discrepancy has been closed, a revised suspicious order monitoring program, and staff retraining records tied to the specific violation found. Our companion piece on the audit-ready controlled substance file covers the recordkeeping that makes this record possible before an investigation starts. A registrant weighing whether to surrender a registration rather than contest it should read our analysis of voluntary surrender forms first; a signed surrender waives the hearing where an acceptance-of-responsibility record could otherwise be built.
Why Early Legal Counsel Is Critical
It is critical that pharmacists and practitioners promptly retain experienced healthcare defense counsel upon receiving a DEA order to show cause, an immediate suspension order, or any other government inquiry touching a controlled substance registration. Early legal intervention can protect the registrant's rights, ensure the response builds an acceptance-of-responsibility record rather than an equivocal one, and preserve defenses that may otherwise be lost. Delaying representation can significantly affect the outcome of the matter.
How Health Law Alliance Can Help
Health Law Alliance defends pharmacists and practitioners in DEA registration denial and revocation proceedings, including the work of building a credible acceptance-of-responsibility record under the public interest factors at 21 U.S.C. § 823(g)(1). Our bench includes a former federal prosecutor and a former senior healthcare compliance executive, background that shapes how we evaluate which corrective measures will move DEA's analysis. If your registration is the subject of a DEA order to show cause or a pending public interest determination, contact us for a free, confidential consultation.
